Cargando…
Deficiency for the Cysteine Protease Cathepsin L Impairs Myc-Induced Tumorigenesis in a Mouse Model of Pancreatic Neuroendocrine Cancer
Motivated by the recent implication of cysteine protease cathepsin L as a potential target for anti-cancer drug development, we used a conditional MycER(TAM);Bcl-x(L) model of pancreatic neuroendocrine tumorigenesis (PNET) to assess the role of cathepsin L in Myc-induced tumor progression. By employ...
Autores principales: | Brindle, Nicola R., Joyce, Johanna A., Rostker, Fanya, Lawlor, Elizabeth R., Swigart-Brown, Lamorna, Evan, Gerard, Hanahan, Douglas, Shchors, Ksenya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415914/ https://www.ncbi.nlm.nih.gov/pubmed/25927437 http://dx.doi.org/10.1371/journal.pone.0120348 |
Ejemplares similares
-
Selective activation of p53-mediated tumour suppression in high-grade tumours
por: Junttila, Melissa R., et al.
Publicado: (2010) -
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018) -
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
por: Chryplewicz, Agnieszka, et al.
Publicado: (2022) -
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets
por: Zacarías-Fluck, Mariano F, et al.
Publicado: (2021) -
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
por: Kortlever, Roderik M., et al.
Publicado: (2017)